Early Detection of Prostate Cancer by Liquid Biopsies

Early Detection of Prostate Cancer by Liquid Biopsies - PROLIPSY

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023458

Enrollment

1628

Registered

2020-11-05

Start date

2019-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: As part of a routine examination, a single blood sample of 40 ml is taken from participating patients before the first prostate biopsy. The aim is to detect circulating tumor cells, circulati

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Serum PSA >4ng/ml

Exclusion criteria

Exclusion criteria: Finasterid treatment

Design outcomes

Primary

Measure	Time frame
Identification of prostate cancer patients	—

Secondary

Measure	Time frame
Identification of high-risk prostate cancer patients	—

Countries

France, Germany, Greece, Italy, Poland

Contacts

Public ContactKlaus Pantel

Universitätsklinikum Hamburg-Eppendorf

tumorbiologie@uke,de+49 (0)40 7410-53503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026